Viking Therapeutics, Inc. (VKTX)
32.13
+0.20
(+0.63%)
USD |
NASDAQ |
Mar 04, 16:00
32.11
-0.02
(-0.06%)
After-Hours: 20:00
Viking Therapeutics Research and Development Expense (Annual) : 344.96M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Pfizer Inc. | 10.25B |
| Amgen, Inc. | 6.974B |
| Hims & Hers Health, Inc. | 149.30M |
| Altimmune, Inc. | 81.99M |